Berenberg Bank Keeps Their Buy Rating on Novo Nordisk (0QIU)
Berenberg Bank's Kerry Holford maintains a Buy rating on Novo Nordisk with a DKK400.00 price target. Holford, a 4-star analyst, has an average return of 11.0% and a 59.09% success rate. Deutsche Bank also issued a Buy rating, while UBS maintained a Hold rating on Novo Nordisk.
In a report released today, Kerry Holford from Berenberg Bank maintained a Buy rating on Novo Nordisk, with a price target of DKK400.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
According to TipRanks, Holford is a 4-star analyst with an average return of 11.0% and a 59.09% success rate. Holford covers the Healthcare sector, focusing on stocks such as Novo Nordisk, Pfizer, and Novo Nordisk.
In addition to Berenberg Bank, Novo Nordisk also received a Buy from Deutsche Bank ‘s Emmanuel Papadakis in a report issued on November 25. However, yesterday, UBS maintained a Hold rating on Novo Nordisk (LSE: 0QIU).
